We Discuss Whether African Equity Empowerment Investments Limited's (JSE:AEE) CEO Is Due For A Pay Rise

Business Wire

Number of Shares and Voting Rights of Innate Pharma as of February 1, 2023

MARSEILLE, France, February 21, 2023–Regulatory News: Pursuant to the article L. 233-8 II of the French “Code de Commerce” and the article 223-16 of the French stock-market authorities (Autorité des Marchés Financiers, or “AMF”) General Regulation, Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (“Innate” or the “Company”) releases its total number of shares outstanding as well as its voting rights as at February 1, 2023: